Coronaviruses
A section of Viruses (ISSN 1999-4915).
Section Information
-coronavirus
-HCoV-OC43
-HCoV-229E
-HCoV-NL63
-HKU1
-SARS-CoV
-MERS-CoV
-MHV
-TGEV
-reverse genetics
-innate immunity
-adaptive immunity
-virus-host interactions
-antivirals
-vaccines
-inactivated vaccines
-live-attenuated vaccines
-reporter viruses
-animal models
-HCoV-OC43
-HCoV-229E
-HCoV-NL63
-HKU1
-SARS-CoV
-MERS-CoV
-MHV
-TGEV
-reverse genetics
-innate immunity
-adaptive immunity
-virus-host interactions
-antivirals
-vaccines
-inactivated vaccines
-live-attenuated vaccines
-reporter viruses
-animal models
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- COVID-19: Prognosis and Long-Term Sequelae, 2nd Edition (Deadline: 31 May 2024)
- Impact of Co-infections in COVID-19: Predisposing Mechanisms and Interplay between Invasive Viral, Bacterial and Fungal Pathogens (Deadline: 31 May 2024)
- COVID-19 Complications and Co-infections (Deadline: 16 June 2024)
- Emerging Concepts in SARS-CoV-2 Biology and Pathology 2.0 (Deadline: 28 June 2024)
- Molecular Epidemiology of SARS-CoV-2, 3rd Edition (Deadline: 30 September 2024)
- Mechanism of Receptor Recognition in Coronavirus (Deadline: 31 October 2024)
- SARS-CoV-2 and mRNA Vaccines, 2nd Edition (Deadline: 29 November 2024)
- COVID-19 and Pneumonia 3rd Edition (Deadline: 31 December 2024)
- Multiple Hosts of SARS-CoV-2: Second Volume (Deadline: 31 December 2024)
- Coronaviruses Pathogenesis, Immunity, and Antivirals (Deadline: 25 January 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
